According to today's presentation, the XanADu results didn't show efficacy because:
* endpoints not sufficiently sensitive
* trial duration too short.
The "not true Alzheimers" factor from the Spark Plus presentation wasn't mentioned.
According to today's presentation, the XanADu results...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $100.3M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.7¢ | 3.5¢ | $172.0K | 4.774M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1115000 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 294396 | 4 |
View Market Depth
| Last trade - 13.10pm 13/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |